ClinicalTrials.Veeva

Menu

Bone Augmentation Techniques in Extraction Sockets

The University of Alabama at Birmingham logo

The University of Alabama at Birmingham

Status

Completed

Conditions

Tooth Loss

Treatments

Other: Amnion Allograft
Other: Allograft

Study type

Interventional

Funder types

Other
Industry

Identifiers

NCT01836783
Amnio-12

Details and patient eligibility

About

The study will compare the density and strength of regenerated bone in extraction sockets after being grafted with two different materials: Bone Allograft and Bone Allograft with Amnion.

The investigators hypothesize that sockets grafted with the Amnion graft will exhibit enhanced healing patterns and will accelerate the formation of regenerated bone in the grafted areas.

Full description

The amniotic allograft is a cryopreserved allograft tissue matrix derived from human placental tissues recovered from live healthy donors. Amniotic tissue is an abundant source of collagen which provides an extracellular matrix to act as a natural scaffold for cellular attachment in the body; collagen provides a structural tissue matrix that facilitates cellular migration and proliferation in-vivo. The product is developed using proprietory techniques by BioDlogics, LLC. The amniotic allograft growth factors are thought to enhance formation of a supportive scaffold for regeneration, to facilitate interactions between cell types, and to influence anti-inflammatory, anti-microbial and immuno-privilege activities.

Atraumatic extractions and socket grafts will be performed. Dental implants will be inserted into the grafted areas 8 weeks post-graft. The implants will be restored and followed for 24 months post-insertion.

Enrollment

22 patients

Sex

All

Ages

19+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  1. Be a registered University of Alabama at Birmingham (UAB) dental school patient
  2. Existence of one or more non-adjacent teeth in the aesthetic zone that are scheduled for extraction
  3. Healthy enough to undergo the proposed therapy
  4. Demonstrated willingness to comply with study directions and time-line
  5. Able to consent for themselves
  6. Able to read and understand the informed consent form -

Exclusion criteria

  1. Pregnant or lactating at the time of enrollment
  2. Previous Malignant neoplasm
  3. Known hypersensitivity to bone grafting materials
  4. Know hypersensitivity to titanium
  5. Any medical of medication that in the opinion of the investigators may adversely affect bone healing
  6. Any indication of an inability to make autonomous decisions -

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

22 participants in 2 patient groups

Amnion Allograft
Experimental group
Description:
Atraumatic tooth extractions and amnion allograft procedures
Treatment:
Other: Amnion Allograft
Allograft
Active Comparator group
Description:
Atraumatic tooth extractions and allograft procedures
Treatment:
Other: Allograft

Trial documents
1

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems